M. Drogoul

High Prevalence of Asymptomatic Sexually Transmitted Infections among Men Who Have Sex with Men

P. Halfon, G. Pénaranda, H. Khiri, 2014, Journal of clinical medicine.

Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor.

T. Allègre, C. Solas, C. Dhiver, 2004, British journal of clinical pharmacology.

Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up.

H. Dumon, N. Schleinitz, C. Mary, 2006, The American journal of tropical medicine and hygiene.

5-Fluoro-uracil-clindamycin for treatment of cerebral toxoplasmosis.

C. Dhiver, I. Poizot-Martin, J. Gastaut, 1993, AIDS.

Etravirine-raltegravir, a marked interaction in HIV-1-infected patients: about four cases.

C. Solas, S. Brégigeon, C. Tamalet, 2009, AIDS.

Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients.

Alain Durand, Nicolas Simon, Bruno Lacarelle, 2007, British journal of clinical pharmacology.

Population Pharmacokinetics of Atazanavir in Human Immunodeficiency Virus-Infected Patients

C. Solas, S. Mokhtari, B. Lacarelle, 2008, Therapeutic drug monitoring.